Express News | ElectroCore Launches Truvaga Plus For General Wellness
Moomoo 24/7Apr 8 08:44 ET
ElectroCore Announces the Launch of Truvaga Plus for General Wellness
ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the launch of its direct-to-consumer mobile
GlobeNewswireApr 8 08:30 ET
Analysts Are Bullish on These Healthcare Stocks: Electrocore (ECOR), Viking Therapeutics (VKTX)
TipRanksMar 15 07:40 ET
Express News | HC Wainwright & Co. Reiterates Buy on ElectroCore, Maintains $15 Price Target
Moomoo 24/7Mar 14 06:52 ET
Electrocore's Growth Trajectory: A Buy Rating With Promising Prospects
TipRanksMar 14 06:27 ET
Earnings Call Summary | ElectroCore(ECOR.US) Q4 2023 Earnings Conference
The following is a summary of the ElectroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript:Financial Performance:ElectroCore reported a significant increase in annual revenue in 2023, growing by 87%
moomoo AIMar 13 21:44 ET · Conference Call
ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates
Yahoo FinanceMar 13 17:25 ET
ElectroCore Q4 2023 GAAP EPS $(0.61), Inline, Sales $5.191M Beat $4.967M Estimate
electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.61) per share which met the analyst consensus estimate. The company reported quarterly sales of $5.191 million which beat the analyst consen
BenzingaMar 13 16:07 ET
Earnings Flash (ECOR) ELECTROCORE Posts Q4 Revenue $5.2M, Vs. Street Est of $5M
04:06 PM EDT, 03/13/2024 (MT Newswires) -- Earnings Flash (ECOR) ELECTROCORE Posts Q4 Revenue $5.2M, vs. Street Est of $5M
MT NewswiresMar 13 16:06 ET
ElectroCore 4Q Loss/Shr 61c >ECOR
ElectroCore 4Q Loss/Shr 61c >ECOR
Dow JonesMar 13 16:05 ET
Earnings Scheduled For March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. • Silence Therapeutics (NASDAQ:SLN) is expec
BenzingaMar 13 06:15 ET
Notable Earnings After Wednesday's Close
Seeking AlphaMar 12 17:35 ET
A Preview Of ElectroCore's Earnings
electroCore (NASDAQ:ECOR) is set to give its latest quarterly earnings report on Wednesday, 2024-03-13. Here's what investors need to know before the announcement.Analysts estimate that electroCore wi
BenzingaMar 12 13:01 ET
ElectroCore to Participate in Upcoming Investor Conferences
ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company's Chief Strategy
GlobeNewswireMar 12 08:00 ET
ElectroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
ROCKAWAY, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the fourth
GlobeNewswireMar 5 16:05 ET
ElectroCore Expands Intellectual Property Portfolio With U.S. Patent No. 11,894,148 Entitled "Systems And Methods For Treating Patients With Diseases Associated With Viruses"
electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trademark Office has issued a patent related to systems an
BenzingaFeb 6 08:11 ET
Express News | HC Wainwright & Co. Maintains Buy on ElectroCore, Raises Price Target to $15
Moomoo 24/7Jan 22 07:33 ET
ElectroCore Expands Intellectual Property Portfolio; Trademark Office Has Issued A Patent Related To Systems And Methods For Treating Post-traumatic Stress Disorder
electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trademark Office has issued a patent related to systems an
BenzingaJan 9 08:10 ET
ElectroCore Expands Intellectual Property Portfolio; The Two Patents Were Issued On December 26, 2023, And Relate To ElectroCore's Non-Invasive Vagus Nerve Stimulation Technology
electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the United States Patent and Trade
BenzingaDec 26, 2023 08:04 ET
ElectroCore Expands Intellectual Property Portfolio
ROCKAWAY, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from
GlobeNewswireDec 26, 2023 08:00 ET
No Data
No Data